1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. REGENXBIO INC
Regenxbio Inc XNAS: RGNX

Regenxbio Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are meta...

Read More
11.21 0.04 (0.36%)
122.42% Gain from 52W Low
623.2K
XNAS Volume

XNAS 07 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Regenxbio Inc is on 11 Nov 2025 for the purpose of Stifel 2025 Healthcare Conference See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
20.3 / 100
Momentum Score
Technically Moderately Bullish
65.1 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
30
1Yr Price target upside is 164%
11 analysts

15

S

11

W

2

O

2

T

SWOT Analysis

Regenxbio Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..